Citation Impact
Citing Papers
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
2005
Cortical 5-HT 2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice
2006 Science
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
Exercise training increases size of hippocampus and improves memory
2011 Standout
Genetic Influences on Brain Gene Expression in Rats Selected for Tameness and Aggression
2014 StandoutNobel
A Sex-Specific Role of Type VII Adenylyl Cyclase in Depression
2006
Sex Differences in the Regulation of Serotonergic Transmission and Behavior in 5-HT Receptor Knockout Mice
2005
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
2006
Effect of Antidepressant Drugs in Mice Lacking the Norepinephrine Transporter
2006
α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression
2010
Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice
1989 StandoutNobel
Cytoskeletal involvement in neuronal learning: a review
1994
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
1990
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats
1989
Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior
2007
Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats
1993
Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)
1993
MK-801-induced stereotypy and its antagonism by neuroleptic drugs
1990
Feeling Strained? Influence of Genetic Background on Depression-Related Behavior in Mice: A Review
2006
Evaluation of the effects of a specific α2-adrenoceptor antagonist, atipamezole, on α1- and α2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine
1997
On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801
1994 StandoutNobel
The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat
1988
Is the forced swimming test a suitable model for revealing antidepressant activity?
1988
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants
2000
5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern
2005
TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment
2008
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
1989
The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor
1989
Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems
1990
The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia
1989
Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders
2008
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Genetic Analysis of Mint/X11 Proteins: Essential Presynaptic Functions of a Neuronal Adaptor Protein Family
2006 StandoutNobel
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice
2014
A Role for MAP Kinase Signaling in Behavioral Models of Depression and Antidepressant Treatment
2006
The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine
1989
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior
2007
Deletion of the miR-379/miR-410 gene cluster at the imprintedDlk1-Dio3locus enhances anxiety-related behaviour
2016
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior
2008
Genetic Regulation of Behavioral and Neuronal Responses to Fluoxetine
2007
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
2011 StandoutNature
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat
1992
Metazoan MicroRNAs
2018 Standout
Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice
2002
Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection
2014
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801
1989
Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication
1995
Effect of MK-801 on endogenous dopamine release in vivo
1990
Par-4 Links Dopamine Signaling and Depression
2005
Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801
1992
Biological basis of the behavior of sick animals
1988 Standout
Behavioral responses to psychomotor stimulant drugs: Localization in the central nervous system
1988
Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine
1998
Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons
1992
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
In vivo effects of a GPR30 antagonist
2009
Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test
1999
Major Depressive Disorder
2008 Standout
Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist
2005
Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor
2010
Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment
2005
The Role of CREB in Depression and Antidepressant Treatment
2006
Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice
1991
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
Herb-Drug Interactions
2005 Standout
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
1989 StandoutNobel
Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects
2007
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders
2008
Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: Effects of fluoxetine and MK-801
2011
Identification of antidepressant drug leads through the evaluation of marine natural products with neuropsychiatric pharmacophores
2007
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice
2005
Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopram
2003
The molecular neurobiology of depression
2008 StandoutNature
MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study
1991
Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization
1993
Automated tests for measuring the effects of antidepressants in mice
2004
Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232
1992 StandoutNobel
Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
1996
Antibody-Mediated Encephalitis
2018 Standout
Fluorine in medicinal chemistry
2007 Standout
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Ferroelectric behavior in microtubule dipole lattices: Implications for information processing, signaling and assembly/disassembly
1995
Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
1982
7-[3-(1-Piperidinyl)propoxy]chromenones as Potential Atypical Antipsychotics
1996
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats
1987
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Cascade Processes of Metallo Carbenoids
1996 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
cAMP Response Element-Binding Protein Is Essential for the Upregulation of Brain-Derived Neurotrophic Factor Transcription, But Not the Behavioral or Endocrine Responses to Antidepressant Drugs
2002
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Disease Tolerance as a Defense Strategy
2012 StandoutScience
A FAAH-Regulated Class of N-Acyl Taurines That Activates TRP Ion Channels
2006 StandoutNobel
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Blockade of MK-801 induced ipsiversive turning in 6-OHDA lesioned rats by α1-adrenoceptor antagonists
1984
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems
1992
Ischemic Cell Death in Brain Neurons
1999 Standout
Restoration of shock‐suppressed behavior by treatment with (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
1982
Elevated anxiety and antidepressant-like responses in serotonin 5-HT 1A receptor mutant mice
1998
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
Animal Behavioural Studies in the Evaluation of Antidepressant Drugs
1992
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
2003 StandoutScience
A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission
2003 StandoutNobel
Light Deprivation Induces Depression-Like Behavior and Suppresses Neurogenesis in Diurnal Mongolian Gerbil (Meriones unguiculatus)
2010
Orchestrated reduction of quantum coherence in brain microtubules: A model for consciousness
1996 StandoutNobel
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
1987 StandoutScience
Physiology of Microglia
2011 Standout
Works of R Chermat being referenced
[Comparison of the sedative effects of 2 alpha-sympathomimetic antihypertensive agents: clonidine and tiamenidine].
1975
Interactions of Ginkgo biloba Extract (EGb 761), Diazepam and Ethyl β-Carboline-3-Carboxylate on Social Behavior of the Rat
1997
The automated tail suspension test: A computerized device which differentiates psychotropic drugs
1987
Microtubule disruption and cognitive defects: Effect of colchicine on learning behavior in rats
1991
Antidepressant-like effects of diphenylhydantoin in mice: Involvement of α-adrenoceptors
1986
The tail suspension test: A new method for screening antidepressants in mice
1985 Standout
Searching—waiting strategy: A candidate for an evolutionary model of depression?
1984
A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in mice
1982
The progressive ratio schedule as a model for studying the psychomotor stimulant activity of drugs in the rat
1983
Pharmacological properties of new antipsychotic agents: use of animal models.
1981
Adaptation of the tail suspension test to the rat.
1987
Use of the automated tail suspension test for the primary screening of psychotropic agents.
1987
Antagonism of hypothermia and behavioral response to apomorphine: A simple, rapid and discriminating test for screening antidepressants and neuroleptics
1981
Comparing benzodiazepines using the staircase test in mice
1987